Toll-like receptors mediate proliferation and survival of multiple myeloma cells (Q40291993)

19 September 2017

title

Toll-like receptors mediate proliferation and survival of multiple myeloma cells (English)

1 reference

19 September 2017

0 references

1 reference

6

1 reference

19 September 2017

7

Espevik T

1 reference

19 September 2017

Bohnhorst J

1

1 reference

19 September 2017

Rasmussen T

2

1 reference

19 September 2017

Moen SH

3

1 reference

19 September 2017

Fløttum M

4

1 reference

19 September 2017

Knudsen L

5

1 reference

19 September 2017

Sundan A

8

1 reference

19 September 2017

publication date

1 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

20

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

1138-1144

1 reference

The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Plasma cell differentiation and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Novel therapeutic approaches for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

New insights into the pathophysiology of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Interleukin-21 is a growth and survival factor for human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Prophylactic antibiotics for the prevention of early infection in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Recognition of pathogen-associated molecular patterns by TLR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Maintenance of serological memory by polyclonal activation of human memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Distinct response of human B cell subpopulations in recognition of an innate immune signal, CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

The immune response modifier resiquimod mimics CD40-induced B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Signaling in B cells via Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-kappaB signal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

mRNA is an endogenous ligand for Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

Toll-like receptors, endogenous ligands, and systemic autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404225

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404225

1 reference

Dimensions Publication ID

19 September 2017

1037717930

0 references

1 reference